Effectiveness of the association of cetirizine and topical steroids in lichen planus pilaris - An open-label clinical trial

Dermatologic Therapy

Volumn 23, Issue 5, 2010, Pages 547-552

  D'Ovidio, Roberto ^a   Rossi, Alfredo ^b   Di Prima, Tiziana Maria ^c  

^a AIDA Tricologia   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

cetirizine; lichen planus pilaris; topical steroid

Indexed keywords

BETAMETHASONE BENZOATE; CETIRIZINE; STEROID; ANTIINFLAMMATORY AGENT; BETAMETHASONE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DARIER DISEASE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HAIR LOSS; HEADACHE; HEART ARRHYTHMIA; HUMAN; LICHEN PLANUS; MALE; RECOMMENDED DRUG DOSE; SEDATION; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA; CLINICAL TRIAL; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CETIRIZINE; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LICHEN PLANUS; MALE; MIDDLE AGED;

EID: 77957296992     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01359.x     Document Type: Article

References (28)

1. Lehman JS, Tollefson MM, Gibson LE. Lichen planus. Review. Int J Dermatol 2009 : 48 : 682 694.
2. Bennion SD, Middleton MH, David-Bajar KM, Brice S, Norris DA. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 1995 : 105 (1 Suppl 71S 79S.
3. Harries MJ, Sinclair RD, MacDonald-Hull S, Whiting DA, Griffiths CE, Paus R. Management of primary cicatricial alopecias:options for treatment. Br J Dermatol 2008 : 159 : 1 22.
4. Jontell M, Hansson HA, Nygren H. Mast cells in oral lichen planus. J Oral Pathol 1986 : 15 : 273. PubMed -5.
5. Zalewska A, Brzezinska-Blaszczyk E, Omulecki A, Pietrzak AA. Functional studies of skin mast cells in lichen planus. Arch Dermatol Res 1997 : 289 (5 261. PubMed -4.
6. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 1984 : 83 (3 214 218.
7. Hayashi S, Hashimoto S. Anti-inflammatory actions of new antihistamines. Clin Exp Allergy 1999 : 29 : 1593 1596.
8. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in general medicine, Third ed. New York : McGraw-Hill, 1987.
9. Theoharides TC, Manolidis SS, Vliagoftis H, Manolidis LS. Treatment of secretory otitis media with local instillation of hydroxyzine. Int Arch Allergy Immunol 1994 : 103 (1 95 101.
10. Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am 1994 : 21 (1 113 119.
11. Dimitriadou V, Pang X, Theoharides TC. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int J Immunopharmacol 2000 : 22 (9 673 684.
12. Caproni M, Palleschi GM, Falcos D, Papi C, Lotti T. Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions. Int J Dermatol 1995 : 34 (7 510 513.
13. Pestelli E, Caproni M, Giomi B, et al. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study. Int J Tissue React 2001 : 23 (3 97 103.
14. Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol 2001 : 19 : 211 225.
15. Danno K, Uehara M. Erythema gyratum repens responding to cetirizine hydrochloride. J Dermatol 2002 : 29 (11 731 734.
16. Sehgal VN, Jain S, Kumar S, Bhattacharya SN, Singh N. Generalized lichen nitidus in a child's response to cetirizine dihydrochloride/levamisol. Australas J Dermatol 1998 : 39 (1 60.
17. Sharma L, Mishra MK. A comparative study of PUVASOL therapy in lichen planus. Indian J Dermatol Venereol Leprol 2003 : 69 (3 212 213.
18. Shimizu T, Nishihira J, Watanabe H, Abe R, Ishibashi T, Shimizu H. Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor: its potential anti-inflammatory action. ClinExp Allergy. 2004 34 (1 103 109.
19. Namazi MR. Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders.J. Int Immunopharmacol 2004 : 4 (3 349 353.
20. Jinquan T, Reimert CM, Deleuran B, Zachariae C, Simonsen C, Thestrup-Pedersen K. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. J Allergy Clin Immunol 1995 : 95 (5 979 986.
21. Ashenager MS, Grgela T, Aragane Y, Kawada A. Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines. J Investig Allergol Clin Immunol 2007 : 17 (1 20 26.
22. Mahmoud F, Arifhodzic N, Haines D, Novotney L. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis. J Pharmacol Sci 2008 : 108 (2 149 156.
23. Namazi MR. Possible molecular mechanisms to account for the involvement of tryptase in the pathogenesis of psoriasis. Autoimmunity 2005 : 38 (6 449 452.
24. Zhao ZZ, Savage NW, Sugerman PB, Walsh LJ. Mast cell/T cell interactions in oral lichen planus. J Oral Pathology Med 2002 : 31 (4 189.
25. d'Ovidio R, Sgarra C, Conserva A, Angelotti UF, Erriquez R, Foti C. Alterated integrin expression in lichen planopilaris. Head Face Med 2007 : 3 : 11.
26. Hemmati AA, Mikaili P, Khodayar MJ, Ghafurian M, Rashidi I. The protective effect of Cetirizine against Bleomycine induced pulmonary fibrosis in rats. Pak J Med Sci 2008 : 24 (6 813 820.
27. d'Ovidio R, Claudatus J, Di Prima T. The Koebner phenomenon in tricology. JEADV 2004 : 18 (Suppl. 2 239.
28. Minogiannis P, El-Mansoury M, Betances J, Sant GR, Theoharides TC. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmac 1998 : 20 (10 553 563.